Evonik’s new methionine complex begins operations in Singapore
Plant has annual capacity of 150,000 metric tons, bringing company’s methionine capacity worldwide up to 580,000 metric tons
The new methionine complex of Evonik Industries in Singapore officially came on stream on November 4, after two years in construction. This plant has an annual capacity of 150,000 metric tons, bringing Evonik’s methionine capacity worldwide up to 580,000 metric tons.
"With this new facility — the most modern of its kind and the first world-scale methionine plant in Asia — we are continuing to expand our market and technology lead in DL-methionine," said Klaus Engel, chairman of the executive board of Evonik Industries. Evonik markets DL-methionine under the MetAMINO brand name.
The company has spent more than EUR500 million (US$627.8 million) on the complex, the most it has ever invested in a single chemical project.
"Methionine is one of our core businesses and Asia is the fastest-growing methionine market in the world. This is why we decided to build here," Engel said.
MetAMINO and all strategically important precursors will be produced in the new methionine complex. "Thanks to our local presence, our complete back-integration in the new plant, and our global production network for MetAMINO, we are able to offer our customers in Asia maximum security of supply," said Dr. Reiner Beste, head of Evonik’s Health & Nutrition Business Unit.
Progress in feed technology, rapid population growth and rising consumption of meat in the region are fuelling Asia’s high methionine demand.
The main reasons for choosing Singapore as the site for the new plant in Asia were the excellent local logistics, the business-friendly, stable environment, and the high level of education. The new production complex will create around 200 jobs for highly qualified individuals.